Postimmunization arthropathy, unspecified ankle and foot
ICD-10 M02.279 is a billable code used to indicate a diagnosis of postimmunization arthropathy, unspecified ankle and foot.
Postimmunization arthropathy refers to joint pain and inflammation that occurs following vaccination. This condition can affect various joints, including the ankle and foot, leading to symptoms such as swelling, stiffness, and pain. Anatomically, the ankle consists of the tibia, fibula, and talus, while the foot comprises multiple bones including the metatarsals and phalanges. The pathophysiology involves an immune-mediated response triggered by the vaccine, which may lead to synovitis and joint effusion. Clinically, patients may present with limited range of motion, tenderness upon palpation, and difficulty bearing weight. The condition is typically self-limiting, but it can significantly impact mobility and quality of life during its course.
Orthopedic documentation should include imaging studies (e.g., X-rays, MRI) to assess joint integrity and functional assessments to evaluate mobility.
Patients may present with acute onset of ankle pain following vaccination, requiring differential diagnosis from traumatic injuries.
Joint-specific considerations include assessing for effusion, range of motion limitations, and potential need for surgical intervention if conservative management fails.
Rheumatologic documentation should include laboratory tests for inflammatory markers (e.g., ESR, CRP) and assessments of disease activity.
Patients may exhibit systemic symptoms alongside localized joint pain, necessitating a comprehensive evaluation for autoimmune conditions.
Consideration of systemic involvement is crucial, as postimmunization arthropathy may mimic other inflammatory arthritides.
Functional assessments should document the patient's ability to perform daily activities and any rehabilitation needs.
Rehabilitation may focus on restoring mobility and strength in the affected joints, particularly after prolonged inactivity.
Mobility limitations may necessitate the use of assistive devices, which should be documented for appropriate coding.
Used for follow-up visits to assess joint symptoms and functional status.
Documentation must include history, examination findings, and treatment plan.
Orthopedic and rheumatologic considerations for ongoing management.
Common symptoms include joint pain, swelling, stiffness, and limited range of motion, typically occurring within weeks of vaccination.
